跳至主要内容
临床试验/DRKS00017069
DRKS00017069招募中不适用

on-interventional prospective research study by d-uo on intravesical instillation of mitomycin C in non-muscle invasive bladder cancer - THUROC

d-uo Deutsche Uro-Onkologen (Interessenverband zur Qualitätssicherung in der Uro-Onkologie in Deutschland e.V.)0 个研究点目标入组 500 人开始时间: 2019年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • 1. age> = 18 years
  • 2. gender: male or female
  • 3. Written consent and consent to the processing of personal data given
  • 4. Patients with histologically confirmed, non-muscle-invasive urothelial carcinoma of the bladder (typical bladder cancer)
  • 5. Patients with planned or performed TUR-B
  • 6. Patients with planned instillation therapy with mitomycin C (Urocin®)

排除标准

  • 1. Presence of a bladder wall perforation
  • 2. Other histological subtype as urothelial carcinoma (e.g., urinary bladder adenocarcinoma, squamous cell carcinoma of bladder)
  • 3. cystitis
  • 4. Hypersensitivity to mitomycin C or another component of Urocin® according to the SmPC
  • 5. Pregnancy or breastfeeding

研究者

发起方
d-uo Deutsche Uro-Onkologen (Interessenverband zur Qualitätssicherung in der Uro-Onkologie in Deutschland e.V.)

相似试验